Free Trial
ASX:SOM

SomnoMed (SOM) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free SOM Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
95,124 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.25%
Price Target
N/A
Stock Analysis
Stock Analysis

About SomnoMed

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

SOM Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive SOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomnoMed and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:SOM
CUSIP
N/A
CIK
N/A
Web
somnomed.com
Phone
61 2 9467 0400
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.09
Net Income
$-10,510,000.00
Net Margins
-11.94%
Pretax Margin
N/A
Return on Equity
-38.28%
Return on Assets
-6.34%

Debt

Debt-to-Equity Ratio
62.00
Current Ratio
1.73
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$88.77 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.61
Book Value
A$0.28 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
108,590,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.02
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Neil Verdal-Austin B.Com.
    C.A., Global CEO, MD & Director
  • Mr. Mark Harding
    Vice President of Global Marketing
  • Mr. Matthew Conlon
    Executive VP of Sales & Marketing - North America
  • Mr. Marco Van Kleef
    Vice President of Marketing & Sales - Europe
  • Mr. Darren Collins ACA (Age 55)
    B Comm, Chief Financial Officer
  • Mr. Terence A. Flitcroft B.Com. (Age 65)
    B.Comm., C.A., SF FIN, Company Secretary
    Comp: $27.25k
  • Mr. Christopher Bedford
    Vice President of Global Production and Product Development

Key Competitors

View All Competitors

Insiders


This page (ASX:SOM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Global crypto currency reset (41 major banks signed up)
Stansberry Research
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals